Belite Bio, Inc (BLTE) Misses Q1 EPS by 5c

Belite Bio, Inc (NASDAQ: BLTE) reported Q1 EPS of ($0.31), $0.05 worse than the analyst estimate of ($0.26).

For earnings history and earnings-related data on Belite Bio, Inc (BLTE) click here.

You May Also Be Interested In

• Apollo Global Management (APO) call put ratio 1 call to 6.8 puts a focus on a spreader of 9K contracts January 95 and 135 puts
• Morgan Stanley Upgrades Sonova Holding AG (SOON:SW) (SONVY) to Equalweight
• EU approves AbbVie's Skyrizi for children with plaque psoriasis